IN2014DN04596A - - Google Patents

Info

Publication number
IN2014DN04596A
IN2014DN04596A IN4596DEN2014A IN2014DN04596A IN 2014DN04596 A IN2014DN04596 A IN 2014DN04596A IN 4596DEN2014 A IN4596DEN2014 A IN 4596DEN2014A IN 2014DN04596 A IN2014DN04596 A IN 2014DN04596A
Authority
IN
India
Prior art keywords
cancer
complexes
relates
present
diagnosing
Prior art date
Application number
Other languages
English (en)
Inventor
Reinout Meijboom
Marianne Jacqueline Cronjé
Original Assignee
Univ Johannesburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johannesburg filed Critical Univ Johannesburg
Publication of IN2014DN04596A publication Critical patent/IN2014DN04596A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5442—Aromatic phosphonium compounds (P-C aromatic linkage)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IN4596DEN2014 2011-12-06 2012-12-06 IN2014DN04596A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA201108944 2011-12-06
PCT/IB2012/057029 WO2013084185A1 (en) 2011-12-06 2012-12-06 Use of silver (i) complexes as anticancer agents

Publications (1)

Publication Number Publication Date
IN2014DN04596A true IN2014DN04596A (enExample) 2015-05-08

Family

ID=47557421

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4596DEN2014 IN2014DN04596A (enExample) 2011-12-06 2012-12-06

Country Status (7)

Country Link
US (2) US9676801B2 (enExample)
EP (1) EP2788007B1 (enExample)
AU (1) AU2012348569B2 (enExample)
CA (1) CA2858325C (enExample)
IN (1) IN2014DN04596A (enExample)
WO (1) WO2013084185A1 (enExample)
ZA (1) ZA201404068B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109705158B (zh) * 2019-01-14 2021-01-05 温州大学新材料与产业技术研究院 一种独立双中心Ag配合物及其制备方法和抗癌活性评价
CN110028526B (zh) * 2019-05-20 2021-07-13 福州大学 高水稳定性兼具蓝绿色发射光及光电响应性能的无机有机杂化材料
CN110041364A (zh) * 2019-05-28 2019-07-23 福建医科大学附属协和医院 一种兼具蓝绿光发光、抗菌和光电响应的高水稳定性无机有机多功能杂化材料
BR102019022373A2 (pt) * 2019-10-24 2021-05-04 Universidade Estadual De Campinas - Unicamp processo de obtenção dos dispositivos de cb-ag-nms e cb-ag-paba, dispositivos de cb-ag-nms e cb-ag-paba e uso dos dispositivos cb-ag-nms e cb-ag-paba

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857549A (en) * 1984-02-01 1989-08-15 Smithkline Beckman Corporation Antitumor compounds
EP0672674B1 (de) * 1988-12-02 2000-05-24 Celanese Chemicals Europe GmbH Sulfonierte Phenylphosphane enthaltende Komplexverbindungen
KR100772790B1 (ko) 2002-04-30 2007-11-01 삼성전자주식회사 금속 패턴 형성용 유기금속 전구체 및 이를 이용한 금속패턴 형성방법
GB0900961D0 (en) * 2009-01-20 2009-03-04 Univ Bath Antimicrobial coating
JP5593705B2 (ja) * 2010-01-19 2014-09-24 セントラル硝子株式会社 トリアルキルホスフィンの製造方法

Also Published As

Publication number Publication date
EP2788007B1 (en) 2020-09-02
EP2788007A1 (en) 2014-10-15
AU2012348569A1 (en) 2014-07-03
US20150037256A1 (en) 2015-02-05
US9676801B2 (en) 2017-06-13
AU2012348569B2 (en) 2016-09-01
US10583109B2 (en) 2020-03-10
CA2858325C (en) 2018-03-13
US20170239208A1 (en) 2017-08-24
ZA201404068B (en) 2015-04-29
WO2013084185A1 (en) 2013-06-13
CA2858325A1 (en) 2013-06-13

Similar Documents

Publication Publication Date Title
PH12014501560A1 (en) Carbamate compounds and of making and using same
PH12012502380B1 (en) Methods of treatment of pancreatic cancer
MY166014A (en) Combination therapy methods for treating proliferative diseases
GB201118656D0 (en) New compounds
NZ729643A (en) Combination therapy for treating cancer
MX366899B (es) Nuevos compuestos.
MY165624A (en) N-acylsulfonamide apoptosis promoters
PH12015501964A1 (en) Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
MY188382A (en) Spirocyclic inhibitors of cathepsin c
IN2012MN02591A (enExample)
MX349004B (es) Nuevos compuestos.
PH12012500497A1 (en) Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs
IL206563A (en) A preparation or drug containing a suspension of blood cells that contain asparaginase for use in the treatment of pancreatic cancer
TN2013000227A1 (en) Use of sigma ligands in bone cancer pain
MX2015011359A (es) Inhibidores macrociclicos de cinasa 2 de repeticion rica en leucina (lrrk2).
MX2022011372A (es) Composiciones de zinc-y-pga y metodos para tratar el cancer.
GB0718878D0 (en) Photodynamic Theraphy and diagnosis
MA34815B1 (fr) Compositions comprenant un inhibiteur de pi3k et un inhibiteur de mek et leur utilisation pour le traitement du cancer
TW201129361A (en) Methods for treating pain
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
WO2008070557A3 (en) Organometallic complexes as therapeutic agents
ZA201404068B (en) The use of silver(i) complexes as active pharmaceutical ingredients (api's) iincluding anticancer agents
WO2012151464A3 (en) Use of radiographic contrast agents for detecting dental caries
PH12013501968A1 (en) Fe(iii) complexes for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias
MX2022008632A (es) Agente de union a ccr5 para el tratamiento de cancer metastasico positivo para ccr5.